C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -104,994 | -84,508 | -52,342 | -26,322 | -105,316 |
| Depreciation Amortization | -783 | -348 | -293 | -327 | -3,578 |
| Accounts receivable | 701 | -3,440 | 901 | -4,926 | 8,697 |
| Accounts payable and accrued liabilities | -468 | 4 | 889 | -645 | -119 |
| Other Working Capital | -29,282 | -22,601 | -6,571 | -13,818 | 7,648 |
| Other Operating Activity | 36,132 | 34,344 | 12,074 | 12,753 | 27,511 |
| Operating Cash Flow | $-98,694 | $-76,549 | $-45,342 | $-33,285 | $-65,157 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -227,074 | -94,003 | -47,320 | -25,640 | -284,321 |
| PPE Investments | -607 | -596 | -185 | N/A | -180 |
| Sale Of Investment | 219,080 | 166,731 | 115,551 | 54,765 | 233,231 |
| Investing Cash Flow | $-8,601 | $72,132 | $68,046 | $29,125 | $-51,270 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 126,318 | 7,633 | 0 | 0 | 45,148 |
| Common Stock Repurchased | -193 | -179 | -155 | -155 | -194 |
| Other Financing Activity | 274 | 273 | 109 | 109 | 382 |
| Financing Cash Flow | $126,399 | $7,727 | $-46 | $-46 | $45,336 |
| Beginning Cash Position | 58,942 | 58,942 | 58,942 | 58,942 | 130,033 |
| End Cash Position | 78,046 | 62,252 | 81,600 | 54,736 | 58,942 |
| Net Cash Flow | $19,104 | $3,310 | $22,658 | $-4,206 | $-71,091 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,694 | -76,549 | -45,342 | -33,285 | -65,157 |
| Capital Expenditure | -607 | -596 | -185 | N/A | -180 |
| Free Cash Flow | -99,301 | -77,145 | -45,527 | -33,285 | -65,337 |